This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB03041/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB03041/identifier/pubchem-compound/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB03041/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03041/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03041
rdf:type
n3:Drug
n3:description
A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. [PubChem]
n3:group
experimental
owl:sameAs
n12:DB03041 n13:DB03041
dcterms:title
Udp-Glucuronic Acid
adms:identifier
n6:46936562 n7:46504863 n8:DB03041 n9:UGA
n3:IUPAC-Name
n4:271B4954-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B495A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4959-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4956-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4957-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4958-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4952-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4950-363D-11E5-9242-09173F13E4C5 n4:271B4953-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4951-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4960-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4961-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B495B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B495C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B495E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B495D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B495F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4966-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4968-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4969-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4965-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4964-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4967-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4955-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4962-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4963-363D-11E5-9242-09173F13E4C5